Skip to main content

Advertisement

Log in

Do clinical and laboratory variables have any impact on the diagnostic performance of 18F-FDG PET/CT in patients with fever of unknown origin?

  • Original Article
  • Published:
Annals of Nuclear Medicine Aims and scope Submit manuscript

Abstract

Objective

To assess the influence of clinical features and laboratory test results on the determination of fever of unknown origin (FUO) by means of 18F-FDG PET/CT.

Methods

Retrospective and longitudinal analysis, including all the PET/CT studies requested for FUO. Reference standard was established by serology, cultures or biopsy with other laboratory tests or clinical follow-up when necessary. Clinical variables, inflammation markers, protein analysis, serology and culture results close to the PET scan were obtained. The final diagnosis was classified into three groups attending to the etiology; group 1: infection or neoplasm, group 2: vasculitis, autoimmune disease or non-infectious inflammatory disease and group 3: auto-limited fever or persistent fever without diagnosis. PET/CT scans were classified as positive or negative and helpful or not in the diagnosis of the fever origin. The effect of clinical features and laboratory variables on the PET/CT results was analyzed.

Results

Sixty-seven patients were evaluated. The final diagnosis was: Group 1 (25), Group 2 (20) and Group 3 (22). 89.6% of patients had a positive inflammation marker, 28.4% proteinogram alterations and 20.9% positive cultures. PET/CT was positive in 52/67 patients. PET/CT helped in the establishment of the fever origin in 35 cases and was especially helpful in groups 1 and 2. Sensitivity, specificity and accuracy of PET/CT were: 84, 31 and 61%. PET results shown significant relations with the final diagnosis (p = 0.035) and culture results (p = 0.037). No significant relations were observed with the rest of clinical or laboratory variables.

Conclusions

18F-FDG PET/CT had a high sensitivity but a low specificity in the diagnosis of the fever origin, probably due to the high rate of diffuse and auto-limited aetiologies. Patients who are most likely to benefit from the PET/CT study would be those with several positive inflammation markers, reflecting a higher pre-test probability of active disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Mourad O, Palda V, Detsky AS. A comprehensive evidence-based approach to fever of unknown origin. Arch Intern Med. 2003;163:545–51.

    Article  PubMed  Google Scholar 

  2. Dong MJ, Zhao K, Liu ZF, Wang GL, Yang SY, Zhou GJ. A meta-analysis of the value of fluorodeoxyglucose-PET/PET-CT in the evaluation of fever of unknown origin. Eur J Radiol. 2011;80:834–44.

    Article  PubMed  Google Scholar 

  3. de Kleijn EM, van Lier HJ, van der Meer JW. Fever of unknown origin (FUO). II. Diagnostic procedures in a prospective multicenter study of 167 patients. The Netherlands FUO Study Group. Medicine (Baltimore). 1997;76:401–14.

    Article  Google Scholar 

  4. Vanderschueren S, Knockaert D, Adriaenssens T, Demey W, Durnez A, Blockmans D, et al. From prolonged febrile illness to fever of unknown origin: the challenge continues. Arch Intern Med. 2003;163:1033–41.

    Article  PubMed  Google Scholar 

  5. Besson FL, Chaumet-Riffaud P, Playe M, Noel N, Lambotte O, Goujard C, et al. Contribution of 18F-FDG PET in the diagnostic assessment of fever of unknown origin (FUO): a stratification-based meta-analysis. Eur J Nucl Med Mol Imag. 2016;43:1887–95.

    Article  CAS  Google Scholar 

  6. Becerra Nakayo M, García Vicente AM, Soriano Castrejón A, Mendoza Narváez JA, Talavera Rubio MP, Poblete García VM, et al. Analysis of cost-effectiveness in the diagnosis of fever of unknown origin and the role of (18)F-FDG PET-CT: a proposal of diagnostic algorithm. Rev Esp Med Nucl. 2012;31:178–86.

    CAS  Google Scholar 

  7. Qiu L, Chen Y. The role of 18F-FDG PET or PET/CT in the detection of fever of unknown origin. Eur J Radiol. 2012;81:3524–9.

    Article  PubMed  Google Scholar 

  8. Crouzet J, Boudousq V, Lechiche C, Pouget JP, Kotzki PO, Collombier L, et al. Place of (18)F-FDG-PET with computed tomography in the diagnostic algorithm of patients with fever of unknown origin. Eur J Clin Microbiol Infect Dis. 2012;31:1727–33.

    Article  CAS  PubMed  Google Scholar 

  9. Durak DT, Street AC. Fever of unknown origin—re-examined and refined. Curr Clin Top Inf Dis. 1991;11:35–51.

    Google Scholar 

  10. Malide D, Davies-Hill TM, Levine M, Simpson IA. Distinct localization of GLUT-1 and—5 in human monocyte-derived macrophages: effects of cell activation. Am J Physiol. 1998;274:E516–E526.

    CAS  PubMed  Google Scholar 

  11. Webb M, Chambers A, Al-Nahhas A, Mason JC, Maudlin L, Rahman L, et al. The role of F-18-FDG-PET in characterising disease activity in Takayasu arteritis. Eur J Nucl Med Mol Imaging. 2004;31:627–34.

    Article  PubMed  Google Scholar 

  12. Blockmans D, de Ceuninck L, Vanderschueren S, Knockaert D, Mortelmans L, Bobbaers H. Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients. Arthritis Rheum. 2006;55:131–7.

    Article  PubMed  Google Scholar 

  13. Seshadri N, Sonoda LI, Lever AM, Balan K. Superiority of 18F-FDG PET compared to 111In-labelled leucocyte scintigraphy in the evaluation of fever of unknown origin. J Infect. 2012;65:71–9.

    Article  CAS  PubMed  Google Scholar 

  14. Buysschaert I, Vanderschueren S, Blockmans D, Mortelmans L, Knockaert D. Contribution of (18)fluoro-deoxyglucose positron emission tomography to the work-up of patients with fever of unknown origin. Eur J Intern Med. 2004;15:151–6.

    Article  PubMed  Google Scholar 

  15. Tokmak H, Ergonul O, Demirkol O, Cetiner M, Ferhanoglu B. Diagnostic contribution of (18)F-FDG-PET/CT in fever of unknown origin. Int J Infect Dis. 2014;19:53–8.

    Article  CAS  PubMed  Google Scholar 

  16. Bleeker-Rovers CP, Vos Fidel J, Mudde Aart H, Dofferhoff Anton SM, de Geus-Oei L-F, Rijnders Anton J. A prospective multi-centre study of the value of FDG-PET as part of a structured diagnostic protocol in patients with fever of unknown origin. Eur J Nucl Med Mol Imag. 2007;34:694–703.

    Article  Google Scholar 

  17. Pereira A, Husmann L, Sah B-R, Battegay E, Franzen D. Determinants of diagnostic performance of 18F-FDG PET/CT in patients with fever of unknown origin. Nucl Med Commun. 2016;37:57–65.

    CAS  PubMed  Google Scholar 

  18. Knockaert DC, Vanderschueren S, Blockmans D. Fever of unknown origin in adults: 40 years on. J Intern Med 2003;253:263–75.

    Article  CAS  PubMed  Google Scholar 

  19. Gaeta GB, Fusco FM, Nardiello S. Fever of unknown origin: a systematic review of the literature for 1995–2004. Nucl Med Commun 2006;27:205–11.

    Article  PubMed  Google Scholar 

  20. De Groot M, Meeuwis AP, Kok PJ, Corstens FH, Oyen WJ. Influence of blood glucose level, age and fasting period on non-pathological FDG uptake in heart and gut. Eur J Nucl Med Mol Imaging. 2005;32:98–101.

    Article  PubMed  Google Scholar 

  21. Kubota K, Nakamoto Y, Tamaki N, et al. FDG-PET for the diagnosis of fever of unknown origin: a Japanese multi-center study. Ann Nucl Med. 2011;25:355–64.

    Article  PubMed  Google Scholar 

  22. Meller J, Sahlmann C-O, Scheel A-K. 18F-FDG PET and PET/CT in fever of unknown origin. J Nucl Med. 2007;48:35–45.

    CAS  PubMed  Google Scholar 

  23. Kouijzer IJ, Bleeker-Rovers CP, Oyen WJ. FDG-PET in fever of unknown origin. Semin Nucl Med. 2013;43:333–9.

    Article  PubMed  Google Scholar 

  24. Pelosi E, Skanjeti A, Penna D, Arena V. Role of integrated PET/CT with [18F]-FDG in the management of patients with fever of unknown origin: a single-centre experience. Radiol Med. 2011;116:809–20.

    Article  CAS  PubMed  Google Scholar 

  25. Manohar K, Mittal BR, Jain S, Sharma A, Kalra N, Bhattacharya A, et al. F-18 FDG-PET/CT in evaluation of patients with fever of unknown origin Jpn. J Radiol. 2013;31:320–7.

    Google Scholar 

  26. Kjaer A, Lebech AM, Eigtved A, Hojgaard A. Fever of unknown origin: prospective comparison of diagnostic value of 18F-FDG PET and 111 In-granulocyte scintigraphy. Eur J Nucl Med Mol Imaging. 2004;31:622–6.

    Article  PubMed  Google Scholar 

  27. Federici L, Blondet C, Imperiale A, Sibilia J, Pasquali JL, Pflumio F, et al. Value of (18)F-FDG-PET/CT in patients with fever of unknown origin and unexplained prolonged inflammatory syndrome: a single centre analysis experience. Int J Clin Pract. 2010;64:55–60.

    Article  CAS  PubMed  Google Scholar 

  28. Keidar Z, Gurman-Balbir A, Gaitini D, Israel O. Fever of unknown origin: the role of 18F-FDG PET/CT. J Nucl Med. 2008;49:1980–5.

    Article  PubMed  Google Scholar 

  29. Balink H, Collins J, Bruyn GA, Gemmel F. F-18 FDG PET/CT in the diagnosis of fever of unknown origin. Clin Nucl Med. 2009;34:862–8.

    Article  PubMed  Google Scholar 

  30. Kim YJ, Kim SI, Hong KW, Kang MW. Diagnostic value of (18)F-FDG PET/ CT in patients with fever of unknown origin. Intern Med J. 2012;42:834–37.

    Article  CAS  PubMed  Google Scholar 

  31. Lorenzen J, Buchert R, Bohuslavizki KH. Value of FDG-PET in patients with fever of unknown origin. Nucl Med Commun. 2001;22:779–83.

    Article  CAS  PubMed  Google Scholar 

  32. Bleeker-Rovers CP, de Kleijn E, Corstens FHM, van der Meer JW, Oyen WJ. Clinical value of FDG-PET in patients with fever of unknown origin and patients suspected of focal infection or inflammation. Eur J Nucl Med Mol Imaging. 2004;31:29–37.

    Article  PubMed  Google Scholar 

  33. Jaruskova M, Belohlavek O. Role of FDG-PET and PET/CT in the diagnosis of prolonged febrile states. Eur J Nucl Med Mol Imaging. 2006;33:913 – 18.

    Article  CAS  PubMed  Google Scholar 

  34. Blockmans D, Knockaert D, Maes A, De Caestecker J, Stroobants S, Bobbaers H, et al. Clinical value of [F-18]fluorodeoxyglucose positron emission tomography for patients with fever of unknown origin. Clin Infect Dis. 2001;32:191–6.

    Article  CAS  PubMed  Google Scholar 

  35. Mulders-Manders C, Simon A, Bleeker-Rovers C. Fever of unknown origin. Clin Med 2015;15:280–84.

    Article  Google Scholar 

  36. Gafter-Gvili A, Raibman S, Grossman A, Avni T, Paul M, Leibovici L, et al. [18F]FDG-PET/CT for the diagnosis of patients with fever of unknown origin. Q J Med. 2015;108:289–98.

    Article  CAS  Google Scholar 

Download references

Funding

No funding has been received.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ana María García-Vicente.

Ethics declarations

Conflict of interest

The authors have no conflict of interest.

Ethical standards

All the procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all the individual participants included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

García-Vicente, A.M., Tello-Galán, M.J., Amo-Salas, M. et al. Do clinical and laboratory variables have any impact on the diagnostic performance of 18F-FDG PET/CT in patients with fever of unknown origin?. Ann Nucl Med 32, 123–131 (2018). https://doi.org/10.1007/s12149-017-1226-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12149-017-1226-8

Keywords

Navigation